Paula Proszek
Royal Marsden NHS Foundation Trust(GB)Royal Marsden Hospital(GB)
Publications by Year
Research Areas
Cancer Genomics and Diagnostics, Advanced Breast Cancer Therapies, Lung Cancer Treatments and Mutations, Cancer Treatment and Pharmacology, Genetic factors in colorectal cancer
Most-Cited Works
- → Mutational Spectrum, Copy Number Changes, and Outcome: Results of a Sequencing Study of Patients With Newly Diagnosed Myeloma(2015)560 cited
- → Signatures of copy number alterations in human cancer(2022)483 cited
- → APOBEC family mutational signatures are associated with poor prognosis translocations in multiple myeloma(2015)312 cited
- → Infant High-Grade Gliomas Comprise Multiple Subgroups Characterized by Novel Targetable Gene Fusions and Favorable Outcomes(2020)273 cited
- → Homologous recombination DNA repair deficiency and PARP inhibition activity in primary triple negative breast cancer(2020)255 cited
- → Evaluating the analytical validity of circulating tumor DNA sequencing assays for precision oncology(2021)255 cited
- → Longitudinal Liquid Biopsy and Mathematical Modeling of Clonal Evolution Forecast Time to Treatment Failure in the PROSPECT-C Phase II Colorectal Cancer Clinical Trial(2018)234 cited
- → Prediction of outcome in newly diagnosed myeloma: a meta-analysis of the molecular profiles of 1905 trial patients(2017)233 cited
- → Results of the c-TRAK TN trial: a clinical trial utilising ctDNA mutation tracking to detect molecular residual disease and trigger intervention in patients with moderate- and high-risk early-stage triple-negative breast cancer(2022)179 cited
- → Inactivating NF1 Mutations Are Enriched in Advanced Breast Cancer and Contribute to Endocrine Therapy Resistance(2019)133 cited